ID   ras/mycSFME
AC   CVCL_A6JT
SY   ras/myc SFME
DR   Wikidata; Q107116708
RX   PubMed=2011405;
RX   PubMed=8376308;
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6JS ! rasSFME
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
CH   CVCL_A6JU ! r/mHM-SFME-1
//
RX   PubMed=2011405;
RA   Rawson, Cathleen L.
RA   Shirahata, Sanetaka
RA   Collodi, Paul
RA   Natsuno, Tetsuya
RA   Barnes, David W.
RT   "Oncogene transformation frequency of nonsenescent SFME cells is
RT   increased by c-myc.";
RL   Oncogene 6:487-489(1991).
//
RX   PubMed=8376308; DOI=10.1007/BF02634544;
RA   Nomura, Takahiro
RA   Matano, Sadaya
RA   Okada, Gensaku
RA   Tokuyama, Haruhiko
RA   Hori, Isao
RA   Nakamura, Shinobu
RA   Kameyama, Tadanori
RA   Ryoyama, Kazuo
RT   "Establishment of a metastatic murine cell line carrying the human
RT   C-Ha-ras.";
RL   In Vitro Cell. Dev. Biol. Anim. 29:614-616(1993).
//